MAKING OMICS APPLICABLE AND ACCESSIBLE IN THE CLINICAL ENVIRONMENT
Clinical OMICs is the leading source of practical insights for pathologists, clinicians, researchers, and scientists working to translate important findings across the broad range of “omics” technologies to deliver on the promise of molecular and precision medicine for patients.
Through a combination of industry news, features, and thoughtful analyses, Clinical OMICs emphasizes the practical—relevant knowledge, and available tools, and empowers healthcare professionals to harness the application of molecular-based technologies and transform patient care. From sequencers and biomarkers to software and clinical decision support and everything in between, Clinical OMICs helps its readers stay current on the most critical research, tools, regulations, and applications affecting the practice of molecular pathology, the development of omics technologies and diagnostics, and the delivery of precision medicine.
Clinical OMICs provides readers with up to date content through it’s bimonthly magazine, weekly newsletter, and daily articles available on ClinicalOMICs.com.
EDITORIAL TEAM
CHRIS ANDERSON
Editor in Chief
JULIANNA LEMIEUX
Senior Editor
ALEX PHILIPPIDIS
Senior News Editor
CAMILLE MOJICA REY
Contributing Editor
CLINICAL OMICS ADVISORY BOARD
ROGER KLEIN
Principal
Roger D. Klein, MD JD Consulting
DANIEL H. FARKAS, Ph.D., HCLD
Section Head, Molecular Pathology
Cleveland Clinic
JEFFREY GIBBS, J.D
Director
Hyman, Phelps, and McNamara
JASON PARK, M.D., Ph.D.
Assistant Professor
Dept. of Pathology
University of Texas
Southwestern Medical Center
STEPHEN C. PEIPER, M.D.
Professor & Chair, Dept. of Pathology
Anatomy & Cell Biology
Thomas Jefferson University
AMIT RASTOGI
Senior Vice President
Strategy, Growth, and Innovation
Inova
DAVID SMITH, Ph.D.
Professor of Laboratory
Medicine and Pathology
Mayo Clinic
KIMBERLY STRONG, Ph.D.
Director, Program in Genomics and Ethics
Medical College of Wisconsin
PETER HARRSCH, Ph.D.
Executive Clinical/Forensic Specialist
Waters Corp.
LARRY WORDEN
Principal
IVD Logix